Page last updated: 2024-10-17

aminocaproic acid and Leukemia, Lymphocytic

aminocaproic acid has been researched along with Leukemia, Lymphocytic in 2 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CATTAN, A1
SCHWARZENBERG, L1
SCHNEIDER, M1
AMIEL, JL1
MATHE, G1
Goldschmidt, B1
Koós, R1

Other Studies

2 other studies available for aminocaproic acid and Leukemia, Lymphocytic

ArticleYear
[TRIAL TREATMENT BY EPSILON-AMINOCAPROIC ACID OF PATIENTS WITH HEMORRHAGIC SYNDROMES, ESPECIALLY SYNDROMES RELATED TO A THROMBOCYTOPENIA].
    La Presse medicale, 1963, Oct-19, Volume: 71

    Topics: Aminocaproates; Aminocaproic Acid; Anemia; Anemia, Aplastic; Humans; Leukemia; Leukemia, Lymphoid; L

1963
Metabolism of fibrinogen in children with acute lymphoblastic leukaemia.
    European journal of pediatrics, 1984, Volume: 143, Issue:2

    Topics: Adolescent; Aminocaproic Acid; Blood Coagulation Tests; Child; Child, Preschool; Disseminated Intrav

1984